Victor L King

Title: Innovator Spotlight: Victor L King - Pioneering Sustained Release Excipient Technology

Introduction:

Victor L King, a talented inventor hailing from Ewing, NJ, has made significant contributions to the pharmaceutical industry with his groundbreaking patent on konjac glucomannan as a sustained release excipient. With a keen eye for innovation and a drive for excellence, King's work has revolutionized the way pharmaceutical tablets are formulated.

Latest Patents:

King holds a single patent for the invention titled "Readily available konjac glucomannan as a sustained release excipient - A solid dosage form." This patent introduces the use of rapidly hydratable konjac glucomannan sustained release excipients such as clarified konjac, cryogenically ground konjac, and plasticized konjac in pharmaceutical tablets. The method involves compressing the excipient and pharmaceutically active ingredient as dry powders, offering a novel approach to drug delivery.

Career Highlights:

Currently associated with FMC Corporation, King has demonstrated a remarkable dedication to advancing pharmaceutical technology. His expertise in sustained release excipients has garnered recognition and accolades within the industry. Through his patent, King has paved the way for enhanced drug release profiles and improved therapeutic outcomes for patients.

Collaborations:

King's innovative work has been complemented by collaborations with esteemed colleagues such as Thomas A Wheatley and David F Erkoboni. Together, they have synergized their expertise to drive forward-thinking solutions in pharmaceutical formulation. The collaborative efforts have resulted in enriched research outcomes and strengthened the foundation for future advancements in drug delivery systems.

Conclusion:

In conclusion, Victor L King's pioneering research in utilizing konjac glucomannan as a sustained release excipient stands as a testament to his ingenuity and commitment to excellence. His contributions have not only reshaped pharmaceutical tablet formulation but have also opened new avenues for sustained drug release technologies. As King continues to push the boundaries of innovation, the industry eagerly anticipates the next wave of transformative advancements in drug delivery systems under his visionary leadership.